NCT03736499

Brief Summary

In this prospective study the investigators want to measure the serum level changes of the thyroid hormones (thyroid-stimulating hormone, reverse triiodothyronine, serum free T4), brain natriuretic peptide (BNP), testosterone and sexual hormone binding protein (SHBG) in adults undergoing cardiac surgery and search for correlations different psychosocial factors and analyze the influence on the survival and the length of ICU/hospital stay.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2018

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 25, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 9, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

January 11, 2022

Status Verified

January 1, 2022

Enrollment Period

2 years

First QC Date

October 25, 2018

Last Update Submit

January 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Length of hospital and intensive care unit stay

    The correlation of the measured pre and postoperative endocrine profile and the length of intensive care unit stay

    Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.

Secondary Outcomes (5)

  • The composite of in-hospital death from any cause.

    Participants will be followed for the duration of hospital stay, an expected average of 12 weeks.

  • Correlation between preoperative Beck Depression Inventory and the length of hospital stay

    Participants will be followed for the duration of hospital stay, an expected average of 12 weeks.

  • Correlation between preoperative State Anxiety Scale and the length of hospital stay

    Participants will be followed for the duration of hospital stay, an expected average of 12 weeks.

  • Correlation between preoperative Trait Anxiety Scale and the length of hospital stay

    Participants will be followed for the duration of hospital stay, an expected average of 12 weeks.

  • Correlation between preoperative EQ-5D inventory and the length of total hospital stay

    Participants will be followed for the duration of hospital stay, an expected average of 12 weeks.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

500 patients of a regional cardiovascular surgery centre

You may qualify if:

  • elective cardiac surgery

You may not qualify if:

  • lack of consent
  • pregnancy
  • acute surgery
  • exposition with iodin-containing contrast material

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Heart and Vascular Center, Semmelweis University

Budapest, 1122, Hungary

Location

Semmelweis Egyetem Heart and Vascular Center

Budapest, 1122, Hungary

Location

Semmeweis Egyetem Heart and Vascular Center

Budapest, 1122, Hungary

Location

Related Publications (9)

  • Aversa A, Fabbri A. Testicular and thyroid function as survival predictors in the elderly patient candidate to surgery. Monaldi Arch Chest Dis. 2017 Jul 18;87(2):841. doi: 10.4081/monaldi.2017.841.

    PMID: 28967725BACKGROUND
  • Brozaitiene J, Mickuviene N, Podlipskyte A, Burkauskas J, Bunevicius R. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study. BMC Cardiovasc Disord. 2016 Feb 18;16:45. doi: 10.1186/s12872-016-0226-2.

    PMID: 26892923BACKGROUND
  • Bianchi V, Mezzani A. Androgens and cardiac diseases. Monaldi Arch Chest Dis. 2013 Dec;80(4):161-9. doi: 10.4081/monaldi.2013.5232.

    PMID: 25087292BACKGROUND
  • Maggio M, Nicolini F, Cattabiani C, Beghi C, Gherli T, Schwartz RS, Valenti G, Ceda GP. Effects of testosterone supplementation on clinical and rehabilitative outcomes in older men undergoing on-pump CABG. Contemp Clin Trials. 2012 Jul;33(4):730-8. doi: 10.1016/j.cct.2012.02.019. Epub 2012 Mar 5.

    PMID: 22414875BACKGROUND
  • Fleischer J, McMahon DJ, Hembree W, Addesso V, Longcope C, Shane E. Serum testosterone levels after cardiac transplantation. Transplantation. 2008 Mar 27;85(6):834-9. doi: 10.1097/TP.0b013e318166ac10.

    PMID: 18360264BACKGROUND
  • Kunst G, Pfeilschifter J, Kummermehr G, Luntz S, Bauer H, Martin E, Motsch J. Assessment of sex hormone-binding globulin and osteocalcin in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2000 Oct;14(5):546-52. doi: 10.1053/jcan.2000.9450.

    PMID: 11052436BACKGROUND
  • Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, Peeters R, Zaman A, Iervasi G. Thyroid Hormones and Cardiovascular Function and Diseases. J Am Coll Cardiol. 2018 Apr 24;71(16):1781-1796. doi: 10.1016/j.jacc.2018.02.045.

  • Szecsi B, Toth K, Szabo A, Eke C, Szentgroti R, Dohan O, Benke K, Radovits T, Polos M, Merkely B, Gal J, Szekely A. Hormonal changes in the first 24 postoperative hours after cardiac surgical procedures. Physiol Int. 2023 Aug 4;110(3):251-266. doi: 10.1556/2060.2023.00219. Print 2023 Sep 5.

  • Toth K, Szabo A, Menyhard J, Benke K, Radovits T, Polos M, Merkely B, Gal J, Szekely A. Poor Preoperative Nutritional Status, but Not Hormone Levels, Are Associated With Mortality After Cardiac Surgery. J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):3074-3083. doi: 10.1053/j.jvca.2022.04.035. Epub 2022 Apr 29.

MeSH Terms

Conditions

Endocrine System Diseases

Study Officials

  • Andrea Székely, ass. prof

    Semmelweis Egyetem

    STUDY DIRECTOR
  • Ágnes Sándor, PhD st

    Semmelweis Egyetem

    PRINCIPAL INVESTIGATOR
  • András Szabó, PhD st

    Semmelweis Egyetem

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 25, 2018

First Posted

November 9, 2018

Study Start

July 1, 2018

Primary Completion

June 30, 2020

Study Completion

May 30, 2022

Last Updated

January 11, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations